ES2174323T3 - Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents

Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Info

Publication number
ES2174323T3
ES2174323T3 ES97951293T ES97951293T ES2174323T3 ES 2174323 T3 ES2174323 T3 ES 2174323T3 ES 97951293 T ES97951293 T ES 97951293T ES 97951293 T ES97951293 T ES 97951293T ES 2174323 T3 ES2174323 T3 ES 2174323T3
Authority
ES
Spain
Prior art keywords
erythromycin
medications
application
preparation procedure
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97951293T
Other languages
English (en)
Inventor
Jean-Michel Auger
Constantin Agouridas
Jean-Francois Chantot
Alexis Denis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2174323T3 publication Critical patent/ES2174323T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I) EN LOS CUALES R RESPRESENTA UN RADICAL ALQUILO OPCIONALMENTE SUSTITUIDO O (CH 2 ) N AR, REPRESENTANDO N UN NUMERO ENTE RO QUE VA DE 0 A 6 Y REPRESENTANDO AR UN RADICAL ARILO O HETEROARILO OPCIONALMENTE SUSTITUIDO Y Z REPRESENTA UN ATOMO DE HIDROGENO O EL RESTO DE UN ACIDO CARBOXILICO. LOS COMPUESTOS DE FORMULA (I) PRESENTAN INTERESANTES PROPIEDADES ANTIBIOTICAS.
ES97951293T 1996-12-12 1997-12-10 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. Expired - Lifetime ES2174323T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615271A FR2757168B1 (fr) 1996-12-12 1996-12-12 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ES2174323T3 true ES2174323T3 (es) 2002-11-01

Family

ID=9498593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97951293T Expired - Lifetime ES2174323T3 (es) 1996-12-12 1997-12-10 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Country Status (28)

Country Link
EP (1) EP0946579B1 (es)
JP (1) JP4363666B2 (es)
KR (1) KR100490074B1 (es)
CN (2) CN1238364C (es)
AP (1) AP997A (es)
AT (1) ATE217008T1 (es)
AU (1) AU721732B2 (es)
BG (1) BG63124B1 (es)
BR (1) BR9714007A (es)
CA (1) CA2273985C (es)
CZ (1) CZ292403B6 (es)
DE (1) DE69712361T2 (es)
DK (1) DK0946579T3 (es)
EA (1) EA001733B1 (es)
ES (1) ES2174323T3 (es)
FR (1) FR2757168B1 (es)
GE (1) GEP20012518B (es)
HU (1) HUP0001180A3 (es)
ID (1) ID21873A (es)
IL (1) IL130420A (es)
NO (1) NO314040B1 (es)
NZ (1) NZ335325A (es)
PT (1) PT946579E (es)
SK (1) SK283715B6 (es)
TR (1) TR199901301T2 (es)
WO (1) WO1998025942A1 (es)
YU (1) YU25699A (es)
ZA (1) ZA9711101B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
TR200102129T2 (tr) * 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
CZ20012675A3 (cs) 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
US6395710B1 (en) * 1999-04-16 2002-05-28 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000071557A1 (en) 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
DK200201957A (da) 2002-12-20 2003-01-20 Alpharma Aps 10-substituted erythromycin ketolides and methods of making

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
DK0638585T3 (da) * 1992-04-22 1996-12-02 Taisho Pharmaceutical Co Ltd 5-O-desosaminylerythronolid-A-derivater
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
JP3709997B2 (ja) * 1994-03-29 2005-10-26 日東電工株式会社 耐熱性ネガ型フォトレジスト組成物および感光性基材、ならびにネガ型パターン形成方法
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
HUP0001180A2 (hu) 2000-09-28
IL130420A0 (en) 2000-06-01
DE69712361T2 (de) 2002-11-28
NZ335325A (en) 2000-08-25
CN100363375C (zh) 2008-01-23
DE69712361D1 (de) 2002-06-06
NO992859D0 (no) 1999-06-11
JP2001506620A (ja) 2001-05-22
CA2273985A1 (fr) 1998-06-18
EP0946579B1 (fr) 2002-05-02
BG63124B1 (bg) 2001-04-30
TR199901301T2 (xx) 1999-08-23
AP997A (en) 2001-08-09
ZA9711101B (en) 1998-12-10
EA001733B1 (ru) 2001-08-27
CZ208299A3 (cs) 1999-09-15
JP4363666B2 (ja) 2009-11-11
AU5487798A (en) 1998-07-03
IL130420A (en) 2003-01-12
FR2757168B1 (fr) 1999-06-11
SK75099A3 (en) 2000-01-18
BG103398A (en) 2000-01-31
BR9714007A (pt) 2000-05-09
WO1998025942A1 (fr) 1998-06-18
CN1721427A (zh) 2006-01-18
EA199900528A1 (ru) 1999-12-29
CN1239966A (zh) 1999-12-29
NO992859L (no) 1999-06-11
NO314040B1 (no) 2003-01-20
CN1238364C (zh) 2006-01-25
FR2757168A1 (fr) 1998-06-19
YU25699A (sh) 2002-06-19
ATE217008T1 (de) 2002-05-15
KR100490074B1 (ko) 2005-05-17
KR20000057517A (ko) 2000-09-15
GEP20012518B (en) 2001-08-27
AU721732B2 (en) 2000-07-13
PT946579E (pt) 2002-10-31
AP9901513A0 (en) 1999-06-30
SK283715B6 (sk) 2003-12-02
CA2273985C (fr) 2007-03-20
EP0946579A1 (fr) 1999-10-06
ID21873A (id) 1999-08-05
CZ292403B6 (cs) 2003-09-17
HUP0001180A3 (en) 2003-05-28
DK0946579T3 (da) 2002-08-12

Similar Documents

Publication Publication Date Title
ES2122472T3 (es) Derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2176698T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
RS49673B (sr) Inhibitori sintaze azot-monoksida
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
BR0314227A (pt) Derivados de amido de hidroxialquila
GR1001619B (el) Παράγωγα ινδόλης.
ES2043625T3 (es) Derivados de acido ariloxicarboxilico, su preparacion y empleo.
ES2140961T3 (es) Nuevos derivados de 19-nor-pregneno.
ATE162796T1 (de) 4-a-substutierte avermectinderivate
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR0008689A (pt) Composição antioxidante
ES2156120T3 (es) Derivados arilamidicos.
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
ES2174323T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2161201T1 (es) Derivado de benzamida, composiciones que contienen dicho derivado y su empleo.
MX9302757A (es) Nuevos pirazoles, proceso para su preparacion y composicion fungicida que los contiene.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
AR006616A1 (es) Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
HK1023346A1 (en) Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them
ES2186191T3 (es) Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento.
AR002749A1 (es) Derivados de estiril bencimidazol y composicion farmaceutica que los comprende.
ES2164454T3 (es) Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 946579

Country of ref document: ES